Roche
RO.SW
#38
Rank
NZ$576.29 B
Marketcap
NZ$724.34
Share price
3.15%
Change (1 day)
34.67%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$34.87

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$34.87. In 2025 the company made an earnings per share (EPS) of NZ$34.87 an increase over its 2024 EPS that were of NZ$19.62.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$34.8777.67%
2024NZ$19.62-32.84%
2023NZ$29.221.95%
2022NZ$28.66-6.29%
2021NZ$30.58-5.53%
2020NZ$32.3816.56%
2019NZ$27.7730.3%
2018NZ$21.3220.22%
2017NZ$17.73-5.81%
2016NZ$18.824.62%
2015NZ$17.99-5.13%
2014NZ$18.97-25.05%
2013NZ$25.3121.73%
2012NZ$20.793.82%
2011NZ$20.028.16%
2010NZ$18.5123.72%
2009NZ$14.96-12.31%
2008NZ$17.06-0.34%
2007NZ$17.1232.13%
2006NZ$12.9642.56%
2005NZ$9.09-22.7%
2004NZ$11.76132.85%
2003NZ$5.05-149.12%
2002NZ-$10.28-209.09%
2001NZ$9.42-57.03%
2000NZ$21.9353.29%
1999NZ$14.3031.24%
1998NZ$10.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.00-45.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.28-64.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-93.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.40-81.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.45-29.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.52-89.89%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.31-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.47-64.23%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.43-81.56%๐Ÿ‡ฌ๐Ÿ‡ง UK